April 24, 2025
Alliance investigators will present more than 20 abstracts at the upcoming 61st Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place May 30–June 3, 2025, in Chicago and online.
This year’s ASCO theme, “Driving Knowledge to Action: Building a Better Future,” emphasizes the vital connection between research and real-world improvements in cancer care. The meeting wil
April 22, 2025
Congratulations to the Carle Cancer Center NCI Community Oncology Research Program for the 2025 Alliance Spring Group Meeting Book cover design. For more than 40 years, Carle Cancer Center has been advancing medicine by providing patients access to a wide range of treatment options, including high-qua
March 26, 2025
Today, the Alliance for Clinical Trials in Oncology was informed that the U.S. Food and Drug Administration has approved cabozantinib for the treatment of patients with previously treated advanced neuroendocrine tumors (NETs). NETs are a type of cancer that manifest characteristics of both nerve and hormone-producing cells, and can arise in
